Business of Cannabis
„Leaked Documents Suggest Significant Changes to Germany’s Cannabis Act“
by Ben Stevens, November 29, 2023
Qoute KFN+:
“We remember the complicated procedure from 2019, which even had to be repeated once and ended with a considerable restriction for the companies that were awarded the contract. Now, any company should be able to apply for the cultivation of medicinal cannabis, without restrictions on the quantity and type of products. The only requirement is that the production is carried out according to the known pharmaceutical principles (GACP, GMP, German monograph for cannabis flowers). The consequences of this development for domestic importers and their import quotas, for the number of new cultivation licences in Germany itself, and thus ultimately for the global world market, cannot be foreseen today.”